Abcombi Biosciences was formed on June 22nd, 2015 based off of research conducted in the Chemical & Biological Engineering Department at the University at Buffalo. Our corporate headquarters are located in Buffalo, New York in Baird Research Park.
Abcombi Biosciences is a pre-clinical vaccine and therapeutic development company dedicated to delivering “smarter” vaccine and anti-infective solutions. To accomplish this, we have developed key technologies and analytical strategies to facilitate our unique protection strategies:
- Our novel biofilm model that mimics the natural progression of disease for colonizing bacteria such Streptococcus pneumoniae and Staphylococcus aureus.
- Bioinformatics, in conjunction with our biofilm model, help to identify antigens associated with specific stages of disease progression.
- A novel coupling mechanism that removes the need for complex chemistry to manufacture polysaccharide conjugate vaccines.
- A broad-spectrum RNA-based therapy for treating influenza infections.
At Abcombi, we harness these potent tools to provide universally protective interventions for complex diseases such as pneumonia and influenza.